Inhibition of Matrix Metalloproteinase-2 and -9 Activities by Selected Flavonoids

Abstract

Matrix metalloproteinases (MMPs) play an important role in physiological and pathological matrix degradation. Here, we report that flavonoids, at physiologically relevant concentrations, inhibit two members of this enzyme family, namely MMP-2 and -9. Eight flavonoids with increasing number of hydroxy groups and other modifications were compared for their capacity to inhibit recombinant catalytic domains of these proteases. EC₅₀ values ranged from 59 and 70 μM (primuletin/5-hydroxyflavone) to 9 and 4 μM (luteolin 7-O-glucoside) for MMP-2 and -9, respectively. Interestingly, the latter glucoside was an equal (MMP-2) or even stronger (MMP-9) inhibitor than its aglycone, luteolin. For luteolin, one of the strongest flavonoids tested, kinetic analysis revealed a non-competitive type of inhibition. Our results add a novel function to the long list of biological effects of these ubiquitous plant constituents that may contribute to and enhance their modulating influence on extracellular matrix degradation and remodelling.

References

• 1 Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis.  Curr Atheroscler Rep. 2004;  6 112-20
• 2 Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix-metalloproteinases: an overview.  Mol Cell Biochem. 2003;  253 269-85
• 3 Kleiner D E, Stetler-Stevenson W G. Matrix metalloproteinases and metastasis.  Cancer Chemother Pharmacol. 1999;  43 42-51
• 4 Stetler-Stevenson W G, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.  Sem Cancer Biol. 1996;  7 147-54
• 5 Gebhardt R. Oxidative stress, Plant-derived antioxidants and liver fibrosis.  Planta Med. 2002;  68 289-96
• 6 Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M, Ito A. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages.  Biochem Pharmacol. 2003;  65 2065-71
• 7 Kim M H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.  J Cell Biochem. 2003;  89 529-38
• 8 Moon S K, Cho G O, Jung S Y, Gal S W, Kwon T K, Lee Y C, Madamanchi N R, Kim C H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9.  Biochem Biophys Res Commun. 2003;  301 1069-78
• 9 Zhang X M, Huang S P, Xu Q. Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway.  Cancer Chemother Pharmacol. 2004;  53 82-8
• 10 Fu X, Kassim S Y, Parks W C, Heinecke J W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase.  J Biol Chem. 2001;  276 41 279-87
• 11 Rice-Evans C. Flavonoids and isoflavones: Absorption, metabolism, and bioactivity.  Free Radical Biology and Medicine. 2004;  36 827-8
• 12 Parellada J, Suárez G, Guinea M. Inhibition of zinc metallopeptidases by flavonoids and related phenolic compounds: Structure-activity relationships.  J Enzyme Inhib. 1998;  13 347-59
• 13 Overall C M, McQuibban G A, Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: A new tool for degradomics.  Biol Chem. 2002;  383 1059-66
• 14 Bormann H, Melzig M F. Inhibition of metallopeptidases by flavonoids and related compounds.  Pharmazie. 2000;  55 29-32
• 15 Gebhardt R. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts.  J Pharmacol Exp Ther. 1998;  286 1122-8
• 16 Knight C G, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.  FEBS Latt. 1992;  296 263-6